Abstract
Increasing numbers of successful pregnancies are reported in recipients of allogeneic hemopoietic stem cell transplantation (HSCT). These may occur naturally, or more commonly, through assisted reproduction. The pregnancy outcomes are usually normal. There are currently no guidelines on the prenatal management of pregnancies involving HSCT recipients. HSCT recipients are unique in that their red cells, lymphocytes and even the DNA in the circulation are donor derived. As a result, typical prenatal screening tests in parents, including mean cell volume (MCV), hemoglobin pattern, blood group, infective serology and DNA screening, are all affected. The MCV cannot be used as guide for iron and folate supplements, or for thalassemia and sickle cell anemia screening. Such screening must be based on pre-HSCT indices and pre-HSCT DNA samples. The risks for hemolytic disease of newborn and hepatitis B virus transmission have to be re-evaluated, based on both pre- and post-HSCT patient as well as donor blood group and serology results. Good communication between obstetricians and the HSCT physician is paramount to promote successful pregnancies in this distinct patient population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Singhal S, Powles R, Treleaven J, Horton C, Swansbury GJ, Mehta J . Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Bone Marrow Transplant 1996; 18: 1049–1055.
Carter A, Robison LL, Francisco L, Smith D, Grant M, Baker KS et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant 2006; 37: 1023–1029.
Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001; 358: 271–276.
Armenti VT, Radomski JS, Moritz MJ, Philips LZ, McGrory CH, Coscia LA . Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2000; 1: 123–134.
Kost K, Landry DJ, Darroch JE . The effects of pregnancy planning status on birth outcomes and infant care. Fam Plann Perspect 1998; 30: 223–230.
Meirow D . Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000; 169: 123–131.
Chung K, Irani J, Knee G, Efymow B, Blasco L, Patrizio P . Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. Eur J Obstet Gynecol Reprod Biol 2004; 113: S7–S11.
Porcu E, Fabbri R, Damiano G, Fratto R, Giunchi S, Venturoli S . Oocyte cryopreservation in oncological patients. Eur J Obstet Gynecol Reprod Biol 2004; 113: S14–S16.
Demeestere I, Simon P, Buxant F, Robin V, Fernandez SA, Centner J et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod 2006; 21: 2010–2014.
Cho SW, Lee SH, Chung MK, Kim HA, Chung HM, Lee YJ et al. Successful spouse pregnancy of male patients with severe aplastic anemia and chronic myelogenous leukemia using spermatozoa banked prior to bone marrow transplantation and using the ICSI procedure: case reports. J Assist Reprod Genet 2004; 21: 59–61.
Sladkevicius P, Saltvedt S, Almstrom H, Kublickas M, Grunewald C, Valentin L . Ultrasound dating at 12–14 weeks of gestation. A prospective cross-validation of established dating formulae in in-vitro fertilized pregnancies. Ultrasound Obstet Gynecol 2005; 26: 504–511.
Qureshi N, Foote D, Walters MC, Singer ST, Quirolo K, Vichinsky EP . Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: a retrospective analysis. Ann NY Acad Sci 2005; 1054: 500–503.
Nieboer P, de Vries EG, Mulder NH, Sleijfer DT, Willemse PH, Hospers GA et al. Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours. Bone Marrow Transplant 2001; 27: 959–966.
Strasser SI, Kowdley KV, Sale GE, McDonald GB . Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 167–173.
Torres A, Sanchez J, Lakomsky D, Serrano J, Alvarez MA, Martin C et al. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation. Haematologica 2001; 86: 24–29.
Franchini M, Gandini G, Aprili G . Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33: 1169–1172.
Lapierre V, Kuentz M, Tiberghien P . Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice. Societe Francaise de Greffe de Moelle. Bone Marrow Transplant 2000; 25: 507–512.
Gandini G, Franchini M, Vassanelli A, De Gironcoli M, Ferro I, Bertuzzo D et al. Immunohematological aspects of bone marrow transplantation. Hematology 2002; 7: 89–93.
Asfour M, Narvios A, Lichtiger B . Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients. MedGenMed 2004; 6: 22.
Au WY, Lie AK, Cheng VC . VDRL screening and haemopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 1027–1028.
Ljungman P, Fridell E, Lonnqvist B, Bolme P, Bottiger M, Gahrton G et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159: 610–615.
Muller I, Brade V, Hagedorn HJ, Straube E, Schorner C, Frosch M et al. Is serological testing a reliable tool in laboratory diagnosis of syphilis? Meta-analysis of eight external quality control surveys performed by the german infection serology proficiency testing program. J Clin Microbiol 2006; 44: 1335–1341.
Au WY, Lie AK, Cheng VC . Hematopoietic progenitor cell transplantation from a donor with indeterminate human immunodeficiency virus antibody status. Transfusion 2005; 45: 819–820.
Holtby I, McCarron B . Immunisation of babies of women who screen positive for hepatitis B. Commun Dis Public Health 2004; 7: 258–259.
Hui CK, Lie A, Au WY, Leung YH, Ma SY, Cheung WW et al. A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood 2005; 106: 464–469. Epub 2005 Mar 29.
Au WY, Lie AK, Liang R, Liu CL, Shek TW, Lau GK . Aggressive hepatocellular carcinoma complicating pregnancy after autologous bone marrow transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant 2002; 29: 177–179.
Stojilkovic-Mikic T, Mann K, Docherty Z, Mackie Ogilvie C . Maternal cell contamination of prenatal samples assessed by QF-PCR genotyping. Prenat Diagn 2005; 25: 79–83.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Au, W., Leung, W. Challenges and pitfalls in prenatal screening in pregnancies involving allogeneic stem cell transplantation recipients. Bone Marrow Transplant 39, 379–382 (2007). https://doi.org/10.1038/sj.bmt.1705604
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705604